These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 4604614

  • 21. Effects of reserpine on rabbit platelet aggregation and adherence to collagen or injured rabbit aorta.
    Cazenave JP, Reimers HJ, Packham MA, Mustard JF.
    Biochem Pharmacol; 1977 Jan 15; 26(2):149-57. PubMed ID: 836333
    [No Abstract] [Full Text] [Related]

  • 22. Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B.
    Morrison DC, Jacobs DM.
    Infect Immun; 1976 Jan 15; 13(1):298-301. PubMed ID: 175019
    [Abstract] [Full Text] [Related]

  • 23. Effects of dilazep on platelet aggregation.
    Nakajima K, Shirai K, Takimoto M, Satoh F, Aoki M.
    Arzneimittelforschung; 1974 Nov 15; 24(11A Suppl):1899-901. PubMed ID: 4480271
    [No Abstract] [Full Text] [Related]

  • 24. Mechanisms of endotoxin tolerance. 8. Specificity of serum transfer.
    Greisman SE, Young EJ, DuBuy B.
    J Immunol; 1973 Nov 15; 111(5):1349-60. PubMed ID: 4583074
    [No Abstract] [Full Text] [Related]

  • 25. Significance of complement to the mechanism of action of endotoxin.
    Mergenhagen SE, Snyderman R, Gewurz H, Shin HS.
    Curr Top Microbiol Immunol; 1969 Nov 15; 50():37-77. PubMed ID: 4907133
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of platelet aggregation by drugs.
    Glusa E.
    Acta Univ Carol Med Monogr; 1972 Nov 15; 52():83-6. PubMed ID: 4669829
    [No Abstract] [Full Text] [Related]

  • 27. Immunological priming without production of circulating bacterial antibodies conditioned by endotoxin and its lipoid A component.
    Neter E, Whang HY, Lüderitz O, Westphal O.
    Nature; 1966 Oct 22; 212(5060):420-1. PubMed ID: 5339135
    [No Abstract] [Full Text] [Related]

  • 28. [Action in vitro of isoxsurprine on platelet aggregation induced by ADP, adrenaline and collagen].
    Di Perri T, Forconi S, Vittoria A, Laghi Pasini F, De Gori V.
    Boll Soc Ital Biol Sper; 1974 Sep 15; 50(17):1385-90. PubMed ID: 4458727
    [No Abstract] [Full Text] [Related]

  • 29. [Action of furosemide on vitro in platelet aggregation by ADP, adrenaline or collagen].
    Vittoria A, Laghi Pasini F, De Gori V, Forconi S, Di Perri T.
    Boll Soc Ital Biol Sper; 1974 Sep 15; 50(17):1391-6. PubMed ID: 4458728
    [No Abstract] [Full Text] [Related]

  • 30. [Action of ethacrynic acid on vitro in platelet aggregation induced by ADP, adrenaline or collagen].
    Vittoria A, Laghi Pasini F, De Gori V, Forconi S, Di Perri T.
    Boll Soc Ital Biol Sper; 1974 Sep 15; 50(17):1397-42. PubMed ID: 4458729
    [No Abstract] [Full Text] [Related]

  • 31. The neurotoxins of gram-negative bacteria: the thermolabile endotoxin.
    Mesrobeanu L, Mesrobeanu I, Mitrica N.
    Ann N Y Acad Sci; 1966 Jun 30; 133(2):685-99. PubMed ID: 5336697
    [No Abstract] [Full Text] [Related]

  • 32. [On the anti-complement and anti-platelet-aggregation action of furosemide and ethacrynic acid. Possibility of a mechanism of action released by the former saluretic in the treatment of acute renal insufficiency].
    Di Perri T, Forconi S, Auteri A, Laghipasini F, Laghi Pasini F, Guercini F.
    Minerva Nefrol; 1974 Jun 30; 21(3):147. PubMed ID: 4463295
    [No Abstract] [Full Text] [Related]

  • 33. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response.
    Amsbaugh DF, Hansen CT, Prescott B, Stashak PW, Asofsky R, Baker PJ.
    J Exp Med; 1974 Jun 01; 139(6):1499-512. PubMed ID: 4151455
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the effects of an antibacterial leukocytic extract and the serum endotoxin-detoxifying component of lipopolysaccharides extracted from rough and smooth Salmonellae.
    Chedid L, Lamensans A, Prixova J.
    J Infect Dis; 1970 Jun 01; 121(6):634-9. PubMed ID: 4987013
    [No Abstract] [Full Text] [Related]

  • 35. Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
    Hager EB, Bailey GL, Hampers CL, Merrill JP.
    Transplant Proc; 1969 Mar 01; 1(1):124-5. PubMed ID: 4944208
    [No Abstract] [Full Text] [Related]

  • 36. Interactions of the complement system with native and chemically modified endotoxins.
    Gewurz H, Mergenhagen SE, Nowotny A, Phillips JK.
    J Bacteriol; 1968 Feb 01; 95(2):397-405. PubMed ID: 4170751
    [Abstract] [Full Text] [Related]

  • 37. Isolation of two types of platelets by collagen-sepharose conjugate and elucidation of their roles in adhesion and aggregation.
    Saito Y, Imada T, Inada Y.
    Thromb Res; 1980 Mar 15; 17(6):809-18. PubMed ID: 7404489
    [No Abstract] [Full Text] [Related]

  • 38. Effects of meningococcal and Escherichia coli capsular polysaccharides on human and dog platelet aggregation in vitro.
    Johnsson H, Niklasson PM.
    J Clin Pathol; 1976 May 15; 29(5):438-40. PubMed ID: 819463
    [Abstract] [Full Text] [Related]

  • 39. A HUMORAL ANTIBODY ASSOCIATED WITH ENDOTOXIN RESISTANCE.
    MUSCHEL LH, JACKSON JE.
    Proc Soc Exp Biol Med; 1964 May 15; 116():182-6. PubMed ID: 14200101
    [No Abstract] [Full Text] [Related]

  • 40. The behaviour of complement and platelets in lethal endotoxin shock in rabbits.
    Brown DL, Lachmann PJ.
    Int Arch Allergy Appl Immunol; 1973 May 15; 45(1):193-205. PubMed ID: 4580374
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.